View in EDS

Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials.
Authors: Mayo T; The University of Alabama at Birmingham, Birmingham, AL, USA., Silverberg JI; The George Washington School of Medicine and Health Sciences, Washington, DC, USA., Armstrong A; University of California Los Angeles, Los Angeles, CA, USA., Guttman-Yassky E; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Blauvelt A; Blauvelt Consulting, LLC, Annapolis, MD, USA., Esdaile B; Whittington Health NHS Trust, London, UK., Kabashima K; Graduate School of Medicine, Kyoto University, Kyoto, Japan., Gooderham M; SKiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough, ON, Canada., Kircik L; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Indiana University School of Medicine, Indianapolis, IN, USA., Schneider S; LEO Pharma Inc., Madison, NJ, USA., Bennike N; LEO Pharma A/S, Ballerup, Denmark., von Eyben R; LEO Pharma A/S, Ballerup, Denmark., Martel BC; LEO Pharma A/S, Ballerup, Denmark., Røpke MA; Previously LEO Pharma A/S, Ballerup, Denmark., Katoh N; Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Alexis AF; Weill Cornell Medicine, New York, NY, USA. drandrewalexis@gmail.com.
Source: American journal of clinical dermatology [Am J Clin Dermatol] 2026 Jan; Vol. 27 (1), pp. 149-166. Date of Electronic Publication: 2025 Oct 21.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100895290 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1888 (Electronic) Linking ISSN: 11750561 NLM ISO Abbreviation: Am J Clin Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41118053
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mayo+T%22">Mayo T</searchLink>; The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Silverberg+JI%22">Silverberg JI</searchLink>; The George Washington School of Medicine and Health Sciences, Washington, DC, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+A%22">Armstrong A</searchLink>; University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Guttman-Yassky+E%22">Guttman-Yassky E</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Blauvelt+A%22">Blauvelt A</searchLink>; Blauvelt Consulting, LLC, Annapolis, MD, USA.<br /><searchLink fieldCode="AU" term="%22Esdaile+B%22">Esdaile B</searchLink>; Whittington Health NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Kabashima+K%22">Kabashima K</searchLink>; Graduate School of Medicine, Kyoto University, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Gooderham+M%22">Gooderham M</searchLink>; SKiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Kircik+L%22">Kircik L</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Indiana University School of Medicine, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Schneider+S%22">Schneider S</searchLink>; LEO Pharma Inc., Madison, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Bennike+N%22">Bennike N</searchLink>; LEO Pharma A/S, Ballerup, Denmark.<br /><searchLink fieldCode="AU" term="%22von+Eyben+R%22">von Eyben R</searchLink>; LEO Pharma A/S, Ballerup, Denmark.<br /><searchLink fieldCode="AU" term="%22Martel+BC%22">Martel BC</searchLink>; LEO Pharma A/S, Ballerup, Denmark.<br /><searchLink fieldCode="AU" term="%22Røpke+MA%22">Røpke MA</searchLink>; Previously LEO Pharma A/S, Ballerup, Denmark.<br /><searchLink fieldCode="AU" term="%22Katoh+N%22">Katoh N</searchLink>; Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Alexis+AF%22">Alexis AF</searchLink>; Weill Cornell Medicine, New York, NY, USA. drandrewalexis@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100895290%22">American journal of clinical dermatology</searchLink> [Am J Clin Dermatol] 2026 Jan; Vol. 27 (1), pp. 149-166. <i>Date of Electronic Publication: </i>2025 Oct 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100895290 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1888 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211750561%22">11750561 </searchLink><i>NLM ISO Abbreviation: </i>Am J Clin Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41118053
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40257-025-00985-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 149
    Titles:
      – TitleFull: Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mayo T
      – PersonEntity:
          Name:
            NameFull: Silverberg JI
      – PersonEntity:
          Name:
            NameFull: Armstrong A
      – PersonEntity:
          Name:
            NameFull: Guttman-Yassky E
      – PersonEntity:
          Name:
            NameFull: Blauvelt A
      – PersonEntity:
          Name:
            NameFull: Esdaile B
      – PersonEntity:
          Name:
            NameFull: Kabashima K
      – PersonEntity:
          Name:
            NameFull: Gooderham M
      – PersonEntity:
          Name:
            NameFull: Kircik L
      – PersonEntity:
          Name:
            NameFull: Schneider S
      – PersonEntity:
          Name:
            NameFull: Bennike N
      – PersonEntity:
          Name:
            NameFull: von Eyben R
      – PersonEntity:
          Name:
            NameFull: Martel BC
      – PersonEntity:
          Name:
            NameFull: Røpke MA
      – PersonEntity:
          Name:
            NameFull: Katoh N
      – PersonEntity:
          Name:
            NameFull: Alexis AF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1888
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: American journal of clinical dermatology
              Type: main
ResultId 1